LRG1 and non-small cell lung carcinoma: Reports have found that CD317, epidermal growth factor receptor (EGFR) in plasma EVs, and human leucine rich alpha-2-glycoprotein 1 (LRG1) in urinary EVs are reliable biomarkers for diagnosing non-small cell lung cancer (NSCLC) [63, 64].